These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34787288)

  • 21. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.
    Lee CH; Lee J; Park YS; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Korean J Intern Med; 2015 Sep; 30(5):629-37. PubMed ID: 26354057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
    Pandey AK; Verma AK; Singh A; Kant S; Dixit RK; Chaudhary SC; Bajpai J; Prakash V; Verma UP
    Cureus; 2022 Dec; 14(12):e32116. PubMed ID: 36601200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified Medical Research Council and COPD Assessment Test Cutoff Points.
    Munari AB; Gulart AA; Araújo J; Zanotto J; Sagrillo LM; Karloh M; Mayer AF
    Respir Care; 2021 Dec; 66(12):1876-1884. PubMed ID: 34670858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD.
    Sun T; Li X; Cheng W; Peng Y; Zhao Y; Liu C; Zeng Y; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1899-1907. PubMed ID: 32848378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could Disease Severity and Inflammatory Markers (IL-6, Hs-CRP, TNF-α) be Related to Frailty in COPD? A Prospective Study.
    R S; M N; L D; N K; G S; Kk B
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai.
    Xie G; Zhang Y; Zhou X; ;
    Chin Med J (Engl); 2014; 127(17):3046-50. PubMed ID: 25189943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
    Giezeman M; Hasselgren M; Lisspers K; Ställberg B; Montgomery S; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3857-3865. PubMed ID: 30568437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Manchester Respiratory Activities of Daily Living Questionnaire: Reliability and Validity of the Chinese Version with Pictorial Enhancement.
    Siu DCH; So CT; Lau CWL; Hui EHM; Fung A; Chan TM; Chan FSF; Chan CKF; Chen WPW; Cheung SHM; Chan KPY; Poon P; Cheung M; Chan C; Tse J; Fung V; Fong KNK
    Int J Chron Obstruct Pulmon Dis; 2021; 16():91-100. PubMed ID: 33488072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease.
    Zhang R; Tan X; He Q; Chen Q; Gai J; Wei J; Wang Y
    Chin Med J (Engl); 2014; 127(14):2594-8. PubMed ID: 25043073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.
    Lee JS; Seo JB; Lee SM; Park TS; Lee SW; Oh YM; Lee JH; Kim EK; Kim TH; Park JH; Sheen SS; Lim SY; Jung I; Lee SD
    J Thorac Dis; 2015 Oct; 7(10):1765-73. PubMed ID: 26623099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological distress and its associated factors among patients with chronic obstructive pulmonary disease in Hunan, China: a cross-sectional study.
    Wang C; Yan J; Ma C
    Sci Rep; 2023 Mar; 13(1):5199. PubMed ID: 36997614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
    Tu YH; Zhang Y; Fei GH
    BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase.
    Vulpi MR; Liotino V; Dragonieri S; Buonamico E; Dimitri M; Capozzolo A; Resta E; Lozupone M; Panza F; Resta O
    Expert Rev Respir Med; 2020 Jun; 14(6):637-643. PubMed ID: 32249627
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).
    Akor AA; Bamidele A; Erhabor GE
    West Afr J Med; 2020; 37(3):275-280. PubMed ID: 32476122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
    Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in classification of COPD patients into risk groups A-D: a cross-sectional study.
    Zogg S; Dürr S; Miedinger D; Steveling EH; Maier S; Leuppi JD
    BMC Res Notes; 2014 Aug; 7():562. PubMed ID: 25148698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health status of COPD patients undergoing pulmonary rehabilitation: A comparative responsiveness of the CAT and SGRQ.
    Sciriha A; Lungaro-Mifsud S; Scerri J; Magro R; Camilleri L; Montefort S
    Chron Respir Dis; 2017 Nov; 14(4):352-359. PubMed ID: 29081264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.